Brown & Brown (BRO) and Its Rivals Financial Survey

Share on StockTwits

Brown & Brown (NYSE: BRO) is one of 19 publicly-traded companies in the “Insurance agents, brokers, & service” industry, but how does it weigh in compared to its peers? We will compare Brown & Brown to similar companies based on the strength of its profitability, earnings, dividends, institutional ownership, analyst recommendations, risk and valuation.

Institutional and Insider Ownership

72.2% of Brown & Brown shares are owned by institutional investors. Comparatively, 64.0% of shares of all “Insurance agents, brokers, & service” companies are owned by institutional investors. 16.7% of Brown & Brown shares are owned by company insiders. Comparatively, 23.2% of shares of all “Insurance agents, brokers, & service” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Brown & Brown and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Brown & Brown $2.01 billion $344.26 million 24.94
Brown & Brown Competitors $13.74 billion $1.05 billion 35.26

Brown & Brown’s peers have higher revenue and earnings than Brown & Brown. Brown & Brown is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of recent recommendations and price targets for Brown & Brown and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brown & Brown 3 4 2 0 1.89
Brown & Brown Competitors 189 688 775 40 2.39

Brown & Brown presently has a consensus target price of $29.33, indicating a potential downside of 4.39%. As a group, “Insurance agents, brokers, & service” companies have a potential upside of 7.63%. Given Brown & Brown’s peers stronger consensus rating and higher possible upside, analysts clearly believe Brown & Brown has less favorable growth aspects than its peers.

Risk and Volatility

Brown & Brown has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, Brown & Brown’s peers have a beta of 0.85, meaning that their average stock price is 15% less volatile than the S&P 500.

Profitability

This table compares Brown & Brown and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Brown & Brown 17.09% 12.03% 5.83%
Brown & Brown Competitors 7.10% 18.05% 9.00%

Dividends

Brown & Brown pays an annual dividend of $0.32 per share and has a dividend yield of 1.0%. Brown & Brown pays out 26.0% of its earnings in the form of a dividend. As a group, “Insurance agents, brokers, & service” companies pay a dividend yield of 1.6% and pay out 32.3% of their earnings in the form of a dividend. Brown & Brown has increased its dividend for 18 consecutive years.

Summary

Brown & Brown peers beat Brown & Brown on 12 of the 15 factors compared.

Brown & Brown Company Profile

Brown & Brown, Inc. markets and sells insurance products in the United States, England, Canada, Bermuda, and the Cayman Islands. Its Retail segment offers property insurance relating to physical damage to property and resultant interruption of business, or extra expense caused by fire, windstorm, or other perils; casualty insurance relating to legal liabilities, professional liability, cyber-liability, workers' compensation, and commercial and private passenger automobile coverages; fidelity and surety bonds; and life, accident, disability, health, hospitalization, medical, dental, and other ancillary insurance products, as well as risk management, loss control surveys and analysis, consultation, and claims processing services. Its National Programs segment offers professional liability and related package insurance products for dentists, oral surgeons, hygienists, lawyers, certified public accountants, optometrists, opticians, ophthalmologists, insurance agents, financial advisors, registered representatives, securities broker-dealers, benefit administrators, real estate brokers and title agents, and escrow agents, as well as supplementary insurance products related to weddings, events, medical facilities, and cyber liabilities. This segment also offers outsourced product development, marketing, underwriting, actuarial, compliance, and claims and other administrative services to insurance carrier partners; and commercial and public entity-related programs, and flood insurance products. Its Wholesale Brokerage segment markets and sells excess and surplus commercial insurance products to retail insurance agencies. Its Services segment offers third-party claims administration and medical utilization management services in the workers' compensation and all-lines liability arenas, Medicare Set-aside, Social Security disability, Medicare benefits advocacy, and claims adjusting services. The company was founded in 1939 and is headquartered in Daytona Beach, Florida.

Receive News & Ratings for Brown & Brown Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brown & Brown and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

$267.75 Million in Sales Expected for Albany International Corp.  This Quarter
$267.75 Million in Sales Expected for Albany International Corp. This Quarter
Conagra Brands Inc  Expected to Post Quarterly Sales of $2.48 Billion
Conagra Brands Inc Expected to Post Quarterly Sales of $2.48 Billion
Paypex Price Tops $0.0193
Paypex Price Tops $0.0193
Zacks: Brokerages Anticipate Domtar Corp  to Post $0.89 Earnings Per Share
Zacks: Brokerages Anticipate Domtar Corp to Post $0.89 Earnings Per Share
ZEON  Trading Down 72.6% This Week
ZEON Trading Down 72.6% This Week
Invesco Emerging Markets Debt Defensive ETF  Trading Up 0%
Invesco Emerging Markets Debt Defensive ETF Trading Up 0%


 
© 2006-2019 Zolmax.